Pipeline to Partnerships (P2P)
Category/Phase: Neurological Diseases / Research |
represents column sort |
|
Title
|
Company Name
|
Platform / Modality
|
Target
|
Investor/Partner Relations
|
CDD-0102 for the Treatment of Alzheimer's Disease |
Cognitive Pharmaceuticals, Ltd. |
Small Molecules |
M1 muscarinic receptors, which play key roles in memory and cognition, as well as initiate beneficial pathways in the brain. |
VC, Licensing, Strategic Partner |
iPUPc (Intelligent Pressure Ulcer Prevention Cushion) |
Medical Technology Systems Inc |
Other (rehab device) |
|
Strategic Partner |
MRI Brain Measurement and Anatomical Localization Service |
Neuromorphometrics, Inc. |
Imaging |
|
VC, Strategic Partner |
Novel Neurorestorative Therapy for Multiple Sclerosis |
Cognosci, Inc. |
Small Molecules |
Rebuilding of myelin and neuroprotective activity and anti-inflammatory |
VC, Licensing, Strategic Partner, Other |
Novel Restorative Therapy for Traumatic Brain Injury |
Cognosci, Inc. |
Small Molecules |
Short and Long Term Improvement of Motor and Behavioral Functions |
VC, Licensing, Strategic Partner, Other |
Ultra Low Profile Angioplasty Balloon Catheter |
Zylon Corporation |
Point of Care |
|
VC, Licensing, Manufacturing, Strategic Partner |
|